HealthSherpa
-7%
est. 2Y upside i
Private sector Healthcare.gov.
Rank
#2458
Sector
HealthTech
Est. Liquidity
~3Y
Data Quality
Data: LowGiven the lack of recent valuation data and uncertain growth, the expected upside over 2 years is slightly negative (-6.8%).
Last updated: July 19, 2026
IPO window opens, multiple expands to 5x forward revenue, exit value $1.125B, driven by category leadership and enrollment growth.
Multiple converges to 3x forward revenue, exit value $675M, resulting in slight loss. Steady but no catalyst.
Regulatory or competitive pressure compresses multiple to 1.5x, exit value $337.5M, a 51.8% decline. Common stock still recovers preference.
Preference Stack Risk
lowFunding Intensity
191%Total preferred stock of $13.4M represents only 1.9% of estimated valuation, minimal overhang.
Dilution Risk
lowCompany generates high revenue, likely self-sufficient; no dilutive raise expected.
Secondary Liquidity
noneNo active secondary market reported.
Other — 1 role
- Don't See What You're Looking For? · Remote (All US)
People & Talent — 1 role
- Principal HRBP · Remote (All US)
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on HealthSherpa's data — designed to show you've done your homework.
- 1
“How does the company plan to mitigate the risk of Healthcare.gov enhancing its own direct enrollment capabilities?”
- 2
“What is the long-term revenue growth strategy beyond ACA enrollments, such as Medicare or international?”
- 3
“Given the lack of recent funding rounds, what is the company's view on employee equity liquidity?”
Community
Valuation Sentiment
Our model estimates -7% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.